LIGAND PHARMACEUTICALS INCORPORATED Derivative, Loss on Derivative
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Derivative, Loss on Derivative of $600.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Notes
us-gaap:DerivativeLossOnDerivative · last filed 2025-05-09
- LIGAND PHARMACEUTICALS INCORPORATED derivative, loss on derivative for the quarter ending 2025-03-31 was $600.00K.
| Period end | Derivative, Loss on Derivative 3 month |
|---|---|
| 2025-03-31 | $600.00K 10-Q · filed 2025-05-09 |